A Community of Leaders in the Development of
Ophthalmic Products, Drugs & Devices.
Innovators/Entrepreneurs • Surgeons • Academia • Venture Capitalists • Industry Leaders • Private & Public Companies
Kicking off the 2nd Annual Ophthalmology Innovation Summit’s segment on Refractive Cataract Surgery, Stephen Slade of Slade & Baker Vision Center, delivers a clinical overview of the importance of refractive cataract surgery, its present state, and possible problems and advancements moving forward with these surgical procedures.
Vance Thompson MD, FACS, Assistant Professor of Ophthalmology for the University of South Dakota School of Medicine and Director of Refractive Surgery for Vance Thompson Vision, highlights the enormous impact of refractive cataract surgery on his practice. Detailing the benefits of accommodating implants in older patients and multifocal implants in younger patients, Vance gives attendees a look into his astounding growth in refractive cataract surgery over the past eight years.
Shareef Mahdavi, President of SM2 Strategic, addresses the attendees of the 2nd Annual Ophthalmology Innovation Summit, delivering an overview of the state of market development in refractive Cataract surgery. Covering data on long-term results, break-down of users and costs related to laser cataract surgery, Shareef details both physician and patient benefits, and positive indicators for the future market.
Jack Holladay, Clinical Professor of Ophthalmology for Baylor College of Medicine and Jim Mazzo, Retired President for Abbott Medical Optics and Executive Chair for Acufocus, lead a panel discussion on Refractive Cataract Surgery at the 2nd Annual Ophthalmology Innovation Summit on April 18, 2013. Lending expert insights into the current challenges and arising opportunities in refractive cataract surgery is a large panel of seasoned executive, academic and medical professionals, which include Laurent Attias of Alcon, Murthy Simhambhatla of Abbott Medical Optics, John Barr of Bausch + Lomb, Nick Curtis of LENSAR, Mark Forchette of OptiMedica, Stephen Slade of Slade & Baker Vision Center, Vance Thompson MD, FACS, of the University of South Dakota School of Medicine and Vance Thompson Vision, and Tom Frinzi of WaveTec.
Delivering a clinical overview of Presbyopia’s IOL and Corneal Technologies at the 2nd Annual Ophthalmology Innovation Summit on April 18, 2013, is Founder and Attending Surgeon for Minnesota Eye Consultants, Richard Lindstrom. Introducing the conference’s segment on the surgical correction of Presbyopia, Richard highlights recent progress and areas for more improvement, from his diverse professional experiences.
Eric D. Donnenfeld
Eric D. Donnenfeld, MD, FAAO, FACS and President Elect for ASCRS, gives the attendees of the 2nd Annual Ophthalmology Innovation Summit a breakdown of the importance of Presbyopia surgery within his practice. Detailing the high levels of patient satisfaction, profitability, and direct and indirect reimbursement to his practice, Eric summarizes the overall benefits this surgery has had on his practice, as well as the possible negative factors that could greatly impact similar practices.
Highlighting the global mega trends that are demanding better vision, Dave Harmon, President for Market Scope, delivers a presentation on the current state of market development in Presbyopia, at the 2nd Annual Ophthalmology Innovation Summit on April 18, 2013. Addressing the compromises and inconsistent results related to the current market of products, Dave notes the potential patient landscape and bright outlook for the future of Presbyopia surgery with improved motivation and consistent results.
Requesting many highly sought after answers to questions surrounding the surgical treatment of Presbyopia, co-moderators Dick Lindstrom, Founder and Attending Surgeon for Minnesota Eye Consultants and Eugene de Juan, Jr., MD, Founder & Vice-Chairman for ForSight Labs, dig into the underlying challenges and emerging possibilities in Presbyopia surgery. Lending their expertise to provide attendees with a comprehensive outlook, panelists Eric D. Donnenfeld, MD, FAAO, FACS, President Elect for ASCRS, David Chang, MD, President for ASCRS and Barry Cheskin, President & CEO and Co-Founder for PowerVision, Inc., deliver responses based on their real-time results and data.
Bill Link, Managing Director for Versant Ventures presents the first ever “Eye on Innovation Award” during the 2nd Annual Ophthalmology Innovation Summit on April 18, 2013. Expressing the importance of SecondSight’s upcoming technology, Bill provides a brief explanation of the …
Bill Link, Managing Director for Versant Ventures presents the first ever “Eye on Innovation Award” during the 2nd Annual Ophthalmology Innovation Summit on April 18, 2013. Expressing the importance of SecondSight’s upcoming technology, Bill provides a brief explanation of the company’s achievement before inviting them to accept the award and present on their innovative technology.
Dr. Gil Kliman, Managing Director for InterWest Partners, introduces the conference’s segment on MIGS at the 2nd Annual Ophthalmology Innovation Summit on April 18, 2013. Giving the attendees an overview of the market and an in depth view of the different approaches, Gil sets the stage for further discussion around Micro-Invasive Glaucoma Surgery.
Addressing the attendees at the 2nd Annual Ophthalmology Innovation Summit with a clinical overview of Micro-Invasive Glaucoma Surgery, Ike K. Ahmed, MD and Assistant Professor for the University of Toronto, details the transition from glaucoma medication to micro-invasive surgery and some of the devices contributing to the successes of this procedure.
Providing the attendees of the 2nd Annual Ophthalmology Innovation Summit with a physician’s perspective on MIGS, Dr. Kerry Soloman of Carolina Eyecare Research Institute, compares the high benefit and low risk MIGS procedure to the success and patient satisfaction in his refractive cataract practice.